Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Athenix Corporation was a prominent agricultural biotechnology company based in Research Triangle Park, North Carolina, that specialized in the discovery and development of novel genes and proteins for crop improvement. The company established one of the world's largest collections of microbial genes, focusing on traits such as insect resistance, herbicide tolerance, and nematode control for major crops like corn, soybeans, and cotton. Utilizing its proprietary discovery platform, Athenix identified high-value genes from soil microbes to engineer next-generation transgenic traits. In 2009, the company was acquired by Bayer CropScience for approximately $365 million, significantly bolstering Bayer's seeds and traits research and development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Athenix.